The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images Adults with a certain type of heartburn now have another option ...

Phathom Pharmaceuticals launched its first broadcast direct-to-consumer (DTC) campaign to promote Voquezna, its treatment for all severities of erosive gastroesophageal reflux disease (GERD), ...

This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality ...

Enjoying fiber-rich fare such as popcorn, oatmeal, beans and avocados throughout the day is also one of the most delicious ...

Phathom Pharmaceuticals (PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a daily ...

In patients with GERD, dominant symptom intensity is a simple patient-reported measure that identifies the most burdensome ...

Most people have experienced heartburn at one time or another, often after a heavy meal. But for some people, that burning pain in the chest can be a frequent occurrence. Gastroesophageal reflux ...

telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...